Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 24,933 | 25,988 | 24,854 | 26,106 | 23,003 |
| Cost of Goods | 5,267 | 5,597 | 5,141 | 5,107 | 4,497 |
| Gross Profit | 19,666 | 20,391 | 19,713 | 20,999 | 18,506 |
| Operating Expenses | 27,156 | 27,607 | 26,997 | 26,006 | 22,438 |
| Operating Income | -7,229 | -6,613 | -7,143 | -4,900 | -3,441 |
| Interest Expense | 826 | 188 | 145 | 129 | 136 |
| Other Income | 47 | 9 | 107 | 27 | 59 |
| Pre-tax Income | -8,008 | -6,792 | -7,181 | -5,002 | -3,518 |
| Income Tax | -165 | 7,936 | -1,530 | -919 | -706 |
| Net Income Continuous | -7,843 | -14,728 | -5,651 | -4,083 | -2,812 |
| Net Income | $-7,843 | $-14,728 | $-5,651 | $-4,083 | $-2,812 |
| EPS Basic Total Ops | -0.56 | -1.06 | -0.41 | -0.29 | -0.20 |
| EPS Basic Continuous Ops | -0.56 | -1.06 | -0.41 | -0.29 | -0.20 |
| EPS Diluted Total Ops | -0.56 | -1.06 | -0.41 | -0.29 | -0.20 |
| EPS Diluted Continuous Ops | -0.56 | -1.06 | -0.41 | -0.29 | -0.20 |
| EBITDA(a) | $-5,023 | $-4,367 | $-4,926 | $-2,568 | $-1,048 |